ZIOPHARM Oncology: Why This Tiny Biotech Has Attracted Fidelity And Other Big In..
Wednesday, July 6, 2011
SOME BIOTECH PROS AND INVESTORS GO AS FAR AS TO PREDICT THAT ZIOPHRAM WILL ULTIMATELY BE A BUYOUT TA .. read more..
Fledgling biotech takes space at Granta Park
Wednesday, July 6, 2011
A biotech startup that used an offer of free facilities at Granta Park, Cambridge to meet potential collaborators and customers has now grown to such a level that it has been able to take space at the science park. Read more... .. read more..
EPA Biotech Regulation Bucks The Scientific Consensus
Wednesday, July 6, 2011
This post was co-written with Drew Kershen, a professor at the University of Oklahoma College of Law.Officials at the Environmental Protection Agency profess an unwavering commitment to science. In their dreams.The bureaucrats\' latest blunder is a flawed fix to a regulatory mess that they created i.. .. read more..
Biotech Stocks: Drug stocks flat, but Pharmasset climbs
Wednesday, July 6, 2011
Drug stocks traded largely flat early Wednesday while Pharmasset shares climbed on a collaboration agreement with Tibotec for hepatitis C drugs. .. read more..
Phalanx Biotech Group Launches Rice Genome OneArray®
Wednesday, July 6, 2011
Phalanx Biotech Group, a global provider of genomic analysis services, announces the newest member to its expression microarray family â the Rice Genome OneArray®. The Rice OneArray® contains 22,003 long-oligonucleotide probes engineered to meet specific isothermal requirements for superb hybridiz.. .. read more..
10 Biotech Trades for Second Half of 2011
Wednesday, July 6, 2011
These trades could represent a watershed moment in the lifeline of a biotech company. Click to view a price quote on SGMO . Click to research the Drugs industry. .. read more..
Md.\'s biotech pitch: We know the Feds
Tuesday, July 5, 2011
State touts access, experience with federal agencies as selling point for biotech industry In the high-cost, high-stakes world of biotechnology innovation, navigating the FDA and the National Institutes of Health — a major source of government research funding — can be a make-or-break experience for.. .. read more..
Maryland\'s biotech pitch: We know the Feds
Tuesday, July 5, 2011
State touts access, experience with federal agencies as selling point for biotech industry In a conference room in downtown Baltimore, F. Blix Winston compared the Food and Drug Administration to a \"slow-moving bulldog.\" .. read more..
Biotech Executive\'s Pay Premium vs Tech: More Cash, Less Equity
Tuesday, July 5, 2011
Compensation in startups is a subject where vague notions of the right comparable benchmarks (“the market rate”) and organizational inertia (“that’s what we’ve done before…”) come together to prevent useful transparency.Mountains of data are thrown at comp committees to determine the next year’s sal.. .. read more..
Biotech Stock Mailbag: Ranking Cheap Biotechs
Friday, July 1, 2011
BOSTON (TheStreet) -- A large share of the email for this week\'s Biotech Stock Mailbag focused on my list of 10 Cheap Biotech Stocks That Could Soar. Steve L. writes, \"Thanks for the article Adam! I\'m always fascinated with biotech and I tried to read and understand your articles as much as I can. I.. .. read more..